Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
MATR
Samsung Biologics
★
Samsung Biologics Decides to Acquire Peptide CDMO PolyPeptide Group for Approximately 2.7 Trillion Won
07/20/2026 07:40 AM
EXCH
Samsung Biologics
★
Samsung Biologics Announces Schedule for First Half 2026 Earnings Release
07/09/2026 04:04 PM
EXCH
Samsung Biologics
★
Samsung Biologics Major Shareholder Holdings Change Report - Negligible 443-Share Decrease No Impact on Stake
07/06/2026 03:39 PM
EXCH
Samsung Biologics
★
Samsung Biologics increases drug manufacturing contract to KRW 215.9 billion and extends to 2037 ensuring long-term revenue stability
06/22/2026 04:55 PM
EXCH
Samsung Biologics
★
Samsung Biologics Secures 835.7 Billion Won CMO Contract Increase with US Pharma, Boosting Long-term Revenue Visibility
06/17/2026 04:11 PM
EXCH
Samsung Biologics
★
Samsung Biologics Signs 400.7 Billion KRW Drug Manufacturing Contract Increase with European Pharma
06/09/2026 04:37 PM
EXCH
Samsung Biologics
★
Samsung Life Insurance Special Account Sells 3,001 Shares of Samsung Biologics via Open Market; Stake Edges Down to 74.30%, Minimal Impact on Shareholder Value
06/01/2026 04:21 PM
EXCH
Samsung Biologics
★
Samsung Biologics Publishes 2026 ESG Report: Transparent Disclosure of Sustainability Performance
06/01/2026 05:39 PM
EXCH
Samsung Biologics
★
Samsung Biologics Corporate Governance Report Disclosed: Excellent Transparency but Neutral Impact Due to Lack of Shareholder Return Policy
06/01/2026 04:03 PM
FTC
Samsung Biologics
★
Samsung Biologics Invests 79.2B KRW in Life Sciences Venture Fund for Future Growth
06/01/2026 04:09 PM
FTC
Samsung Biologics
★
Samsung Biologics Annual Conglomerate Disclosure – Sound Financials, Stable Ownership at 74.39% by Affiliates, No Material Events
06/01/2026 01:02 PM
OWNR
Samsung Biologics
★
Samsung Biologics Exec Jo Seong-hwan Withdraws 50 Shares from ESOP
05/20/2026 05:05 PM
PERI
Samsung Biologics
★★★
Samsung Biologics: Strong Q1 2026 Results and US Production Base Acquisition
05/15/2026 04:12 PM
PERI
Samsung Biologics
★★
Samsung Biologics: 2025 Consolidated Revenue +30%, Operating Profit +57%... Spin-off Focuses on CDMO
05/15/2026 03:50 PM
EXCH
Samsung Biologics
★
Samsung Life Insurance Special Account Slightly Sells Samsung Biologics Shares; No Change in Major Shareholder Stake
05/04/2026 04:49 PM